Radiopharmaceutical Production (FDG)

Fluorodeoxyglucose (FDG) is a radiopharmaceutical used in PET/CT imaging to support diagnosis and treatment planning. RMC produces FDG using cyclotron-based isotope generation followed by synthesis and quality control.

What is FDG?

FDG is a glucose analog labeled with fluorine-18. After administration, it accumulates in tissues with increased glucose metabolism and can be detected by PET/CT imaging.

Production Overview

  • Isotope production using the cyclotron.
  • Radiochemical synthesis in controlled modules.
  • Quality control testing before release.

Clinical Context

FDG PET/CT is used across oncology, neurology, and cardiology, subject to clinical protocols and physician judgment.